Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| General Counsel and Secretary | Scimeca Dario | Feb 18, 2026 | Sell | $18.91K | 4,925 |
| Chief Research Officer | SMITH J. JEFFERSON | Feb 18, 2026 | Sell | $18.91K | 4,925 |
| CFO | Kelly John Alexander | Feb 18, 2026 | Sell | $31.29K | 8,149 |
| CEO | Amoroso Michael | Feb 18, 2026 | Sell | $78.95K | 20,559 |
| CEO | Amoroso Michael | Jan 22, 2026 | Sell | $145.11K | 34,799 |
| Chief Research Officer | SMITH J. JEFFERSON | Jan 21, 2026 | Sell | $41.11K | 10,200 |
| CFO | Kelly John Alexander | Jan 21, 2026 | Sell | $61.31K | 15,213 |
| General Counsel and Secretary | Scimeca Dario | Jan 21, 2026 | Sell | $35.68K | 8,854 |
| Director | Frankel Stanley | Dec 16, 2025 | Buy | $12.69K | 2,700 |
| Director | Germano Geno J | Dec 16, 2025 | Buy | $14.16K | 3,000 |
| Director | Brown Melinda | Dec 15, 2025 | Buy | $6.86K | 1,381 |
| General Counsel and Secretary | Scimeca Dario | Nov 3, 2025 | Sell | $4.32K | 665 |
| CEO | Amoroso Michael | Nov 3, 2025 | Sell | $22.12K | 3,409 |
| CFO | Kelly John Alexander | Nov 3, 2025 | Sell | $8.46K | 1,303 |
| Director | Frankel Stanley | Sep 26, 2025 | Buy | $13.42K | 2,700 |
| Director | Brown Melinda | Sep 22, 2025 | Buy | $6.85K | 1,400 |
| CFO | Kelly John Alexander | Jul 3, 2025 | Sell | $63.16K | 14,827 |
| Director | Brown Melinda | Jun 25, 2025 | Buy | $6.96K | 1,682 |
| Director | Buehler Kevin | Jun 25, 2025 | Buy | $21.12K | 5,076 |
| Director | Brown Melinda | Mar 26, 2025 | Buy | $8.74K | 1,839 |
| Director | Buehler Kevin | Mar 26, 2025 | Buy | $21.12K | 4,523 |
| Director | Germano Geno J | Mar 25, 2025 | Buy | $17.23K | 3,250 |
| CEO | Amoroso Michael | Mar 24, 2025 | Sell | $5.36K | 964 |
| General Counsel and Secretary | Scimeca Dario | Mar 4, 2025 | Sell | $1.34K | 272 |
| Chief Research Officer | SMITH J. JEFFERSON | Mar 4, 2025 | Sell | $756.14 | 154 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.